The Exchange has received the disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Yash Sunil Chari
ROSSARI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Rossari Biotech Ltd has received a disclosure under Regulation 29(1) and 29(2) of SEBI's Substantial Acquisition of Shares & Takeovers Regulations, 2011, from Yash Sunil Chari. These regulations require parties to disclose their intention to acquire or sell shares before crossing key thresholds under the takeover code. The filing is a standard pre-deal intimation to the exchange, but the headline does not specify whether the transaction is a buy or a sell, nor the size of the proposed stake change. Investors should wait for the detailed disclosure or a board announcement to understand the exact nature and magnitude of the proposed deal.
This is a routine regulatory disclosure and does not by itself indicate a change in control. Shareholders should monitor for further details on the direction (purchase or sale) and quantum of shares involved, as this could affect short-term price action and promoter holding levels.